AT VERACYTE WE BELIEVE
Exceptional cancer care begins with exceptional diagnostics.
Veracyte’s molecular tests empower clinicians with the high-value insights they need in the race to diagnose and treat cancer.
PROVIDING HIGH-VALUE INSIGHTS
Clinicians and patients may struggle with uncertainty during cancer diagnosis and treatment decision-making. Our tests can help them move forward with confidence.
OUR proven framework
Veracyte’s approach to diagnostics
We collaborate closely with clinicians and scientists to identify unmet needs that stand in the way of better care. And then, we find the answers. Our rigorous process enables more confident decision-making for clinicians, giving patients access to a higher standard of care.
We seek to make leading diagnostics accessible to patients all over the world.
400K
>7M
1
Identify clinical unmet needs
We work with clinicians and scientists to develop our tests. Through a rigorous multi-disciplinary innovation process we identify unmet needs and create solutions that make clinicians’ and patients’ lives easier.
2
Develop high-performance tests
We take a rigorous approach to ensuring product performance and utility, building evidence across a broad range of studies. Clinicians and patients need high-quality, reliable results they can trust.
3
Ramp patient testing globally
We make our leading diagnostics widely available through a flexible CLIA- and in vitro diagnostic (IVD)-based model. We supplement this with our proven ability to build clinical evidence that drives reimbursement, encourages clinician adoption, and prompts guideline inclusion for our tests.
Making our tests available worldwide
Through our centralized CLIA lab-based approach in the US and our growing menu of distributed IVDs to serve global markets, we aim to transform cancer care for patients all over the world.
Join our team
Veracyte offers fulfilling career opportunities for curious, driven, and patient-oriented people who are inspired to find answers to some of the most challenging questions in medicine. Join us.
REFERENCES
Company data on file.
Cancer. World Health Organization. Published February 3, 2022. Accessed July 19, 2023. https://www.who.int/news-room/fact-sheets/detail/cancer
Thyroid Cancer – Statistics. Cancer.Net. Accessed July 19, 2023. https://www.cancer.net/cancer-types/thyroid-cancer/statistics
Bladder Cancer. International Agency for Research on Cancer. Accessed July 19, 2023. https://www.iarc.who.int/cancer-type/bladder-cancer/